Cancel
Austin Rynders
Senior Director, Clinical Operations
@
Clene Nanomedicine
5w26p8@1f4g3.22h
Sign up to see email
Known information
- Has over 10 years of clinical experience heavily focused in CNS/pain methodology.
- Has an emphasis in investigational pain modeling, abuse potential, degenerative disorders, and unique early proof-of-concept study development across Phase I-III studies.
- Participated in and oversaw over 200 clinical trials prior to joining Clene.
- Developed and implemented validated methodologies surrounding ventilatory responses to hypercapnia and quantitative sensory testing.
- Developed and beta tested cognition-based assessment platforms.
- Led the operational reorganization of multiple clinical operations teams.
- Expanded and developed a purpose-built 136 bed Phase 1 facility.
- Received a Bachelor of Nursing from the University of Utah.
- Will soon obtain a Master of Science in Pharmacology and Toxicology from Michigan State University.
About Clene Nanomedicine
Clene Nanomedicine is a biopharmaceutical company focused on developing nanotherapeutics for neurodegenerative diseases, with its lead candidate, CNM-Au8, targeting ALS, MS, and Parkinson's Disease.
Report inaccurate information
